Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection

Direct-acting antivirals (DAAs) have dramatically improved the management of chronic hepatitis C (CHC). In this study, we investigated the effects of hepatitis C virus clearance on markers of systemic inflammation measured in plasma samples from CHC patients before, during and after DAA therapy. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorin, Jean-Baptiste, Malone, David F. G., Strunz, Benedikt, Carlsson, Tony, Aleman, Soo, Björkström, Niklas K., Falconer, Karolin, Sandberg, Johan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005788/
https://www.ncbi.nlm.nih.gov/pubmed/32034167
http://dx.doi.org/10.1038/s41598-020-58768-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005788/
https://www.ncbi.nlm.nih.gov/pubmed/32034167
http://dx.doi.org/10.1038/s41598-020-58768-z

Ejemplares similares